Connect to other sites within the UBM Medica Network
Intermittent ADT Upped Risk for Ischemic, Thrombotic Events
Men with prostate cancer assigned to intermittent ADT experienced more ischemic and thrombotic events than did men assigned to continuous ADT.
Urinary Markers May Predict Response to Re-irradiation of Bone Metastases
In a recently published study, patients who did not respond to initial radiation or re-irradiation of symptomatic bone metastases had significantly higher urinary markers of bone turnover at baseline and follow-up.
Radiation Response in Breast Cancer Bone Metastases
Researchers were able to demonstrate response to radiotherapy in breast cancer patients with osteolytic metastases by measuring increases in bone density.
RT Effective for Palliation of Bone Metastases From HCC
A recent study found that radiation therapy was effective for the palliation of painful spinal metastases in patients with hepatocellular carcinoma.
Childhood Cancer Survivors at Risk for Hormone Deficiencies After Radiotherapy
A new study finds that childhood cancer survivors are at risk for pituitary hormone deficiencies after radiotherapy treatment to the head.
Adoption of Hypofractionated Radiotherapy in Early-Stage Breast Cancer
The benefit of hypofractionated radiotherapy for women receiving breast-conserving therapy for early-stage breast cancer is becoming more apparent.
Socioeconomic Factors Affecting Use of Radiation Therapy in Hodgkin Lymphoma
Socioeconomic factors are reducing the use of combined-modality treatment for early-stage Hodgkin lymphoma, despite its association with increased survival.
Why I Went Into Radiation Oncology
In this video, Dr. Yu discusses why he went into radiation oncology and what he has learned during his time in practice.
By clicking Accept, you agree to become a member of the UBM Medica Community.